APRE

Aprea Therapeutics Inc
4.57
-0.04 (-0.87%)
Stock Name Stock Symbol Market Stock Type
Aprea Therapeutics Inc APRE NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
-0.04 -0.87% 4.57 03:07:32
Open Price Low Price High Price Close Price Previous Close
4.59 4.57 4.65 4.61
more quote information »

Recent News

Date Time Source Heading
16/3/202323:00GLOBEAprea Therapeutics Announces Presentation of Preclinical..
13/3/202321:05EDGARCurrent Report Filing (8-k)
08/3/202300:00GLOBEAprea Therapeutics to Present at Oppenheimer’s 33rd Annual..
03/3/202322:06EDGARStatement of Ownership (sc 13g)
02/3/202308:05GLOBEAprea Therapeutics Regains Compliance with Nasdaq Minimum..
28/2/202310:37EDGARStatement of Changes in Beneficial Ownership (4)
28/2/202308:05GLOBEAprea Therapeutics Announces Closing of $5.5 Million..
25/2/202309:29EDGARCurrent Report Filing (8-k)
25/2/202309:24EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
23/2/202312:41GLOBEAprea Therapeutics Announces Pricing of $5.5 Million..
23/2/202308:05GLOBEAprea Therapeutics Announces Proposed Public Offering of..
16/2/202300:00GLOBEAprea Therapeutics Announces Phase II SBIR Award from the..
14/2/202322:02EDGARCurrent Report Filing (8-k)
13/2/202323:00GLOBEAprea Therapeutics Announces One-for-Twenty Reverse Stock..
11/2/202308:34EDGARCurrent Report Filing (8-k)
31/1/202309:20EDGARInitial Statement of Beneficial Ownership (3)
31/1/202308:47EDGARCurrent Report Filing (8-k)
31/1/202300:00GLOBEAprea Therapeutics Appoints John Hamill as Chief Financial..
27/1/202300:01EDGARCurrent Report Filing (8-k)
20/1/202300:00GLOBEAprea Therapeutics to Participate in 6th Annual DNA Damage..
12/1/202301:25APSBiotech Bid Up Following First Patient Dosage
12/1/202300:00GLOBEAprea Therapeutics Announces Dosing of First Patient in..
10/1/202300:02EDGARCurrent Report Filing (8-k)
16/12/202209:02EDGARSecurities Registration: Employee Benefit Plan (s-8)
18/11/202208:32EDGARCurrent Report Filing (8-k)
16/11/202209:09EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
10/11/202222:25TRMNH.C. Wainwright Reaffirms Their Buy Rating on Aprea..
10/11/202209:02EDGARQuarterly Report (10-q)
10/11/202208:15GLOBEAprea Therapeutics Reports Third Quarter 2022 Financial..
27/10/202208:01EDGARProxy Statement (definitive) (def 14a)
23/9/202208:00GLOBEAprea Therapeutics Announces Poster Presentation at the 2022..
17/9/202206:32EDGARCurrent Report Filing (8-k)
08/9/202222:00GLOBEAprea Therapeutics to Participate in the 2022 H.C...
03/9/202206:47EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
20/8/202206:31EDGARCurrent Report Filing (8-k)
13/8/202206:33EDGARQuarterly Report (10-q)
12/8/202206:15GLOBEAprea Therapeutics Reports Second Quarter 2022 Financial..
03/8/202206:31EDGARCurrent Report Filing (8-k)
02/8/202222:00GLOBEAprea Therapeutics to Participate in the 2022 Wedbush..
02/8/202207:05EDGARStatement of Changes in Beneficial Ownership (4)
02/8/202207:05EDGARStatement of Changes in Beneficial Ownership (4)
02/8/202207:04EDGARStatement of Changes in Beneficial Ownership (4)
02/8/202207:02EDGARStatement of Changes in Beneficial Ownership (4)
30/7/202206:32EDGARCurrent Report Filing (8-k)
20/7/202202:04BNZGThis Financial Services Stock Is Trading Higher By 50%, Here..
02/7/202207:05EDGARCurrent Report Filing (8-k)
01/7/202206:36EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
11/6/202207:01EDGARProxy Statement (definitive) (def 14a)
08/6/202207:05EDGARStatement of Changes in Beneficial Ownership (4)
08/6/202207:03EDGARStatement of Changes in Beneficial Ownership (4)
Your Recent History
NASDAQ
APRE
Aprea Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230329 16:22:42